17 results on '"Shingami T"'
Search Results
2. IgG heavy chain allotype (Gm), a genetic marker for human chromosome 14q32, and haematopoietic malignancies
3. P-381 Apparent involvement of cellular immunity in the mechanism of hepatic cell damage and dysfunction associated with HCV hepatitis (CHC) patients
4. [Immunogenetic studies on etiology of liver disease --HLA and liver cirrhosis (author's transl)].
5. [Reactivity with nucleic acid of selfsynthesized omega, omega'-diguanylspermidine--3HCl (DGSD) and spermidine 3HCl (author's transl)].
6. [Studies on HLA-DR typing method --micro lymphocyte cytotoxicity test (author's transl)].
7. [Immunogenetic studies on etiology of liver disease --HLA in HBs-Ag cluster family (author's transl)].
8. [Immunogenetic studies on etiology of liver disease --HLA and primary hepatoma (author's transl)].
9. [Immunogenetic studies on etiology of liver disease --HLA and chronic hepatitis (author's transl)].
10. [Screening test of tumor potency of chemicals against sarcoma 180 ascites tumor cells (author's transl)].
11. [Studies on behavior of trace metal and carrier protein in patients with cancer --behavior of zinc, copper, iron, ceruloplasmin and transferrin in blood (author's transl)].
12. [Immunogenetic studies on etiology of liver diseases - with HLA (human leucocyte antigen) as a genetic marker- (author's transl)].
13. [A case with gastric cancer by OK-MF'C therapy (author's transl)].
14. [Immunogenetic studies on etiology of liver disease --HLA in asymptomatic carriers with positive HBs-Ag (author's transl)].
15. [Effect of omega,omega'-diguanylspermidine 3HCl (DGSD) and spermidine 3HCl on Ehrlich ascites tumor cells (author's transl)].
16. IgG heavy chain allotype (Gm), a genetic marker for human chromosome 14q32, and haematopoietic malignancies.
17. [Studies of the behavior of PA, RBP in the blood in various liver diseases (author's transl)].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.